San Francisco, California 94110


The purpose of this study is to find out how the amount of fat or sugar in a person's diet, or the number of meals eaten each day, affect the amount of fat that people's bodies make, the types of fats in the bloodstream, and how much fat is stored in the liver. The study is funded by the National Institutes of Health.

Study summary:

The study consists of two 10-day feeding periods that are separated by approximately two weeks. During each feeding period all food and beverages to be consumed will be provided by the study. In Study 1, participants will be randomly assigned to receive one of two diets. Both diets are designed to maintain weight at a constant level. The diets are balanced nutritionally and have the same amount of protein. One diet has higher amounts of sugar, while the other has higher amounts of fat. For one 10-day period, the diet will be fed as two large meals ('meal-feeding'). For the other 10-day period, the identical diet will be fed as 8 small meals ('nibbling'). Half of the participants will meal-feed first, while the other half will 'nibble' first. The order of nibbling or meal feeding will be determined randomly. In Study 2, the number of meals eaten per day will remain fixed at three (no nibbling or meal feeding). Participants will receive both the diet higher in sugar and the diet higher in fat. However, they will be randomly assigned to start one followed by the other for each 10-day feeding period. At the end of each 10-day feeding period, participants will spend two nights in a research ward (Clinical Research Center) to undergo testing.


Inclusion Criteria: - overweight or obese men and women - ages 20-65 years Exclusion Criteria: - pregnancy or lactation within the past six months - type 1 or 2 diabetes mellitus] - AST and ALT above upper limit of normal (ULN) - fasting triglyceride or total cholesterol levels >ULN - Hgb below the lower of limit of normal - positive HIV antibody test or hepatitis serologies - use of any antidiabetic medications or lipid-lowering drugs - history of surgery for obesity - change in body weight >5% within preceding 6 months (self report) - claustrophobia, presence of metal implants - weight over 350 lbs



Primary Contact:

Principal Investigator
Kathleen Mulligan, PhD
University of California, San Francisco

Kathleen Mulligan, PhD
Phone: 415 206 5882

Backup Contact:

Michael J. Wen, MS
Phone: 415 206 5532

Location Contact:

San Francisco, California 94110
United States

There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source:

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.